EUVIMEDEUVIMED entdecken
Crossref

A CRISPR ‐Cas9‐based tool for dose‐dependent DNA damage detection

Valentyn Oksenych iD, Pavlo Petakh, Denis Kainov, Oleksandr Kamyshnyi

The FEBS Journal · 2025

DOI: 10.1111/febs.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Valentyn Oksenych und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, DNA Breaks, Double-Stranded, DNA Damage, Saccharomyces cerevisiae. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Auboiron et al. developed a CRISPR‐Cas9‐based system in yeast Saccharomyces cerevisiae that allows precise, dose‐dependent induction of DNA double‐strand breaks by targeting Ty retrotransposons. This system combines sequence specificity with control over break numbers (×1, ×15, or ×59), enabling a more detailed and precise study of DNA damage response. It revealed that the key DNA damage response kinase, Tel1, localizes to the nuclear periphery and forms multiple foci after induction of DNA double‐strand breaks. The system also exposed limitations in Cas9 availability at higher break levels and offers a scalable platform for studying genome stability across organisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsDNA Breaks, Double-StrandedDNA DamageSaccharomyces cerevisiaeProtein Serine-Threonine KinasesRetroelementsSaccharomyces cerevisiae ProteinsIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

ATCRISPR‐Cas9DNA double‐strand breaksNHEJTel1homologous recombination

Substanzen

Protein Serine-Threonine KinasesRetroelementsSaccharomyces cerevisiae ProteinsTEL1 protein, S cerevisiaeIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
  • Department of Biochemistry and Pharmacology, Uzhhorod National University, Ukraine.
  • Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, Ukraine.

ORCID-Profile: Valentyn Oksenych

Zitieren

APA

Oksenych, V., Petakh, P., Kainov, D., & Kamyshnyi, O. (2025). A CRISPR ‐Cas9‐based tool for dose‐dependent DNA damage detection. The FEBS Journal. https://doi.org/10.1111/febs.70186

Vancouver

Oksenych V, Petakh P, Kainov D, Kamyshnyi O. A CRISPR ‐Cas9‐based tool for dose‐dependent DNA damage detection. The FEBS Journal. 2025. doi:10.1111/febs.70186

BibTeX
@article{Oksenych2025,
  author = {Oksenych, Valentyn and Petakh, Pavlo and Kainov, Denis and Kamyshnyi, Oleksandr},
  title = {A CRISPR ‐Cas9‐based tool for dose‐dependent DNA damage detection},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70186}
}
Kostenlos starten →